The relationship between the increase in catecholamine levels of the coronary sinus blood and the amplitude of various cardiac responses to adrenergic nerve stimulation was studied in anesthetized dogs. Plasma catecholamine levels in both coronary sinus and aortic blood were measured by a modification of the radiometric enzymatic assay for tissue catecholamines and were found to be 0.622 ± 0.104 (SE) ng/ml and 0.933 ± 0.116 ng/ml, respectively, under basal conditions. The catecholamine levels in coronary sinus blood increased linearly during right cardioaccelerator nerve stimulation up to a frequency of 10 Hz. At this frequency, maximum values were observed in both coronary sinus blood catecholamine levels and cardiac responses. The correlation between the response in heart rate, mean coronary blood flow, and dP/dt of left ventricular pressure and the increase in endogenous catecholamine levels of coronary sinus blood was significant, but the relationship was nonlinear. The present experimental design may prove to be a reliable means of studying the role of the sympathetic nervous system in the regulation of cardiovascular function in vivo.
• The release of norepinephrine from the heart in response to direct stimulation of sympathetic nerves has been reported previously, but attempts to correlate the amount of endogenous neurotransmitter liberated with the intensity of physiological responses in vivo have been limited (1) (2) (3) (4) (5) . For instance, an overflow of endogenous norepinephrine produced by a short period of stimulation has never been demonstrated at very low stimulation frequencies despite the fact that most innervated tissues respond physiologically to a frequency range of 1 to 3 Hz (6) . Moreover, in previous studies, multiple sampling of blood during short periods of stimulation has been prevented by the lack of sensitive, specific methods for the measurement of plasma catecholamines; as a result, accurate correlations with physiological responses have not been made.
The recent development of radiometric enzymatic assay techniques has provided new means for the detection of small quantities of catecholamines (7) (8) (9) . An adaptation of the assay for tissue catecholamines previously developed by Coyle and Henry (9) to plasma catecholamines allows changes in endogenous catecholamines released from the heart to be measured in a small volume of blood collected at short intervals from the coronary sinus; hence, catecholamine release can now be correlated with various parameters of the cardiac response following sympathetic nerve stimulation.
The present report describes a close relationship between changes in endogenous catecholamine levels in coronary sinus blood and those in heart rate, mean coronary blood flow, and the first derivative of left ventricular pressure (dP/dt) in anesthetized dogs.
Methods

PREPARATION OF THE DOG
Thirteen mongrel dogs (9.6-19 kg) were anesthetized with sodium pentobarbital (35 mg/kg, iv). Artificial respiration was maintained through a tracheal tube with a Harvard pump. A bilateral thoractomy was performed at the level of the fourth intercostal space, and both vagus nerves were cut at the neck. The coronary sinus and the left femoral artery were cannulated and connected with polyethylene tubes to the left jugular vein and the distal right femoral artery, respectively. These extracorporeal bypasses permitted frequent collections of blood samples through a three-way stopcock attached to each tube. Sodium heparin (200 units/kg) was administered intravenously before the extracorporeal bypasses 6 6 2 Circulation Research, Vol. 36, May 1975 were opened, and 100 units/kg of heparin was then given every 2 hours.
Aortic pressure, left ventricular pressure and its first derivative (dP/dt), heart rate, mean coronary blood flow in the left anterior descending coronary artery, and a peripheral lead electrocardiogram (aVR) were recorded with a Grass polygraph (model 7). Left ventricular pressure was measured with a catheter-tip manometer (Millar Mikro-Tip transducers model PC-470), and mean coronary artery blood flow was measured with an electromagnetic blood flowmeter (Statham model SP-2202). dP/dt of left ventricular pressure was obtained by using a differentiator circuit patched on an analog computer (Electronic Associates Inc. model . The response of this differentiator was linear (± 5%) through 60 Hz. The right stellate ganglion was stimulated with bipolar platinum electrodes at supramaximal intensity (10 v) for a period of 1 minute (2 msec duration; 1, 3, 10, and 30 Hz) with a Grass simulator (model S-4).
For measurements of endogenous catecholamines, 4-ml blood samples were collected simultaneously from the coronary sinus and the aorta in about 30 seconds during each stimulation period, i.e., from 30 seconds after the onset of stimulation to the end of stimulation.
ASSAY FOR PLASMA CATECHOLAMINES
The amount of catecholamines was measured according to an adaptation of the method of Coyle and Henry (9) for measurements in plasma.
Immediately after sampling, blood was centrifuged at -2°C, 10,000 rpm for 20 minutes, and plasma was transferred to another chilled tube. Plasma proteins were removed by adding 2N perchloric acid containing 1% EGTA and 70 mM magnesium chloride in a proportion of 1 ml of the acid solution to 9 ml of plasma. The plasma-acid mixture was agitated on a Vortex for 30 seconds, centrifuged at room temperature, 2,000 rpm for 10 minutes, and stored in a refrigerator (0-4°C) until assay. Catechol-O-methyltransferase was prepared and purified from rat liver by the method of Axelrod and Tomchick (10) . The principle of this technique is based on the conversion of norepinephrine and epinephrine to tritiated normetanephrine and metanephrine in the presence of catechol-O-methyltransferase and tritiated S-adenosylmethionine as a labeled methyl donor. A 300-//liter sample of supernatant fluid obtained from the plasma-acid mixture was placed in a 13-ml glass-stoppered centrifuge tube. Duplicated samples were taken for each assay. In a third tube containing 300 //liters of the supernatant fluid, 0.5 ng of i-norepinephrine (free base) in 10 //liters of 0.1N perchloric acid was added, thus providing an internal standard for the assay. Blanks consisted of 300 //liters of Ringer's solution. The reaction was initiated by adding 100 //liters of a mixture containing 500 ng of dithiothreitol, 0.5 //moles of MgCl 2 , 140 //moles of Tris-HCl buffer, pH 9.6, 25 //liters of catechol-O-methyltransferase, and 2.5 //c of tritiated Sadenosylmethionine (specific activity 4.55 c/mM, New England Nuclear Corp.). The reaction mixture was incubated at 35°C for 60 minutes. Tritiated vanillin formed from the normetanephrine by oxidation with sodium periodate was counted in a Packard liquid scintillation spectrometer (TRI-CARB model 526).
All extraction procedures were those of Coyle and Henry (9) . The concentration of plasma catecholamines (NE) (ng/ml) was obtained by correcting for the amount of norepinephrine in the internal standard as follows:
(counts/min (counts/min NE (ng/ml) = ofsample) -ofblank) (counts/min (counts/min of standard) -ofsample) 0.5ngofNE , ". ... x x 1,000 //liters. 270//liters The assay procedure for norepinephrine showed linearity with various amounts of norepinephrine ranging from 0.1 to at least 20 ng. This technique permitted accurate measurement of levels as low as 0.025 ng of norepinephrine. For statistical evaluation of the difference between various results, Student's t-test was used.
Results
REPRODUCIBILITY OF THE ASSAY FOR PLASMA CATECHOLAMINES
The mean catecholamine concentration in aortic blood obtained from 13 dogs under basal conditions was significantly higher (P < 0.01) than that in coronary sinus blood ( Table 1 ). The control circulating catecholamine levels in both coronary sinus and aortic blood were variable during a given experimental period, but these variations were not statistically significant.
Circulating catecholamine levels in coronary sinus blood significantly increased three-to fourfold during stimulation (10 Hz, 1 minute) of the right cardioaccelerator nerves, but those in aortic blood did not change significantly. This catecholamine overflow from the heart was reproducible on repetition of the same stimulation three times at 60-minute intervals ( Fig. 1 ).
Cardiac responses also increased during the same stimulations and were highly reproducible within a given experimental period. The responses in heart rate for example ( Fig. 1 ) corresponded to the increases in plasma catecholamine levels in coro- nary sinus blood during the same period of cardioaccelerator nerve stimulation. Basal values for heart rate, mean coronary blood flow, and dP/dt of left ventricular pressure are given in Table 1 .
FREQUENCY-RESPONSE CURVES OF PLASMA CATECHOLAMINE LEVELS AND CARDIAC RESPONSES
In a separate series of experiments, the right cardioaccelerator nerves were stimulated with different frequencies of 1, 3, 10, and 30 Hz. A frequency-dependent increase in catecholamine levels in coronary sinus blood was obtained up to 10 Hz, but the values obtained at 30 Hz were lower than those observed at 10 Hz (Fig. 2 ). Circulating catecholamine levels in aortic blood did not change significantly during the experimental period.
Frequency-response curves similar to those of coronary sinus blood catecholamine levels were simultaneously obtained for heart rate, mean coronary blood flow in the left anterior descending coronary artery, and dP/dt of left ventricular pressure (Fig. 2) . The cardiac responses were also frequency dependent up to 10 Hz, whereas the responses obtained at 30 Hz were less important than those observed at 10 Hz. However, it was evident from these frequency-response curves that a slight increase in coronary sinus catecholamine levels at 3 Hz (29% of the maximum response) was accompanied by considerably more important responses in heart rate, mean coronary blood flow, and left ventricular dP/dt-82%, 76%, and 64% of the maximum response, respectively. Consequently, the relationship between the intensity of the cardiac responses and the catecholamine levels in coronary sinus blood was not linear.
CORRELATION BETWEEN THE CONCENTRATION OF CATECHOL AMINES MEASURED IN CORONARY SINUS BLOOD AND THE CARDIAC MANIFESTATIONS OF ADRENERGIC ACTIVITY
Although the physiological responses were not directly dependent on the level of circulating catecholamines in the blood, it was assumed on the Frequency-response curves relating the plasma catecholamine levels, heart rate, mean coronary blood flow (CBF), and dP/dt of left ventricular pressure (LVP) to various frequencies of right cardioaccelerator nerve stimulation. The results are expressed as the increment above each control value. The maximum response was obtained at a frequency of 10 Hz. Each point represents the mean ± SE for six dogs for mean coronary blood flow and eight dogs for the other parameters. All results were statistically greater than the control value at the level of P < 0.05. basis of their linear increase in response to stimulation frequencies of 1-10 Hz that the catecholamine levels in the venous effluent closely reflected the amount of neurotransmitter liberated at the nerve terminals.
The increments in heart rate, mean left coronary blood flow, and left ventricular dP/dt obtained during right cardioaccelerator nerve stimulation were plotted as a function of the corresponding increases in coronary sinus blood catecholamine concentrations. Since the cardiac responses increased more at lower frequencies, a nonlinear relationship was anticipated. When the catecholamine levels were plotted along a logarithmic scale, a regression line could be approximated between changes in coronary sinus catecholamines and left ventricular dP/dt, coronary blood flow, and heart rate ( Figs. 3-5 ). The best correlation was found with dP/dt which had an r value of 0.743 j (Fig. 5 ), and the poorest correlation, although it was still significant, was found with heart rate (r = 0.428, Fig. 3 ).
Discussion
The present results suggest that the cardiac responses and the catecholamine content of the venous effluent from the heart are quite closely related during electrical stimulation of the right cardioaccelerator nerve at various frequencies in the anesthetized dog.
The method of measuring endogenous plasma catecholamine content used in these experiments proved to be sensitive, accurate, and highly reproducible on repetition of electrical stimulation at a given frequency and voltage within a given experimental period of over 150 minutes. Circulating catecholamine levels in coronary sinus blood were lower than those measured in aortic blood under basal conditions. This difference probably indicates the capacity of the sympathetic Correlation between endogenous catecholamines released from the heart into the coronary sinus blood and the corresponding dP/dt of left uentricular pressure (dp/dt LVP). Changes in catecholamine levels and dP/dt were produced by electrical stimulation of the right cardioaccelerator nerves. The points shown in this figure represent the increment above control values obtained in eight dogs. The changes in endogenous catecholamine levels are expressed on a logarithmic scale.
fibers of the heart to take up circulating norepinephrine on its passage through the coronary bed. The ability of the heart to extract exogenously administered norepinephrine has been well documented (11) (12) (13) . Similar differences in the arteriovenous concentrations of endogenous norepinephrine have been observed in the heart in vivo (3) and in the perfused cat calf muscle preparation in situ (14) . These latter investigations have also demonstrated, after the reuptake mechanism has been blocked, that norepinephrine is spontaneously released by adrenergically innervated organs. The spontaneous release of neurotransmitter from the heart under basal conditions has been observed in our laboratory, using tritium-labeled norepinephrine in an animal preparation similar to that described in the present study (15) .
Most previous experiments in which norepinephrine overflow in response to nerve stimulation has been studied were carried out using stimulation frequencies ranging from 10 to 50 Hz or more (16) (17) (18) (19) (20) (21) (22) (23) . In these experiments carried out on isolated, perfused organs, the amount of norepinephrine released into the venous effluent or perfusate was determined mainly by bioassay techniques (16) (17) (18) (19) , spectrofluorometric measurements (22) , or through the use of labeled norepinephrine (20, 21, 23) . Mainly because previous techniques have lacked the sensitivity needed to detect small changes in the levels of endogenous catecholamines in the plasma, it has been impossible to accurately measure the effects of low-frequency stimulation on the order of 1-3 Hz and correlate them with physiological responses under basal conditions so far in vivo. Release of norepinephrine in response to l^w-frequency stimulation has been demonstrated by Haefely et al. (24) using the perfused cat spleen preparation, but measurements were made only after the reuptake mechanism was blocked by continuously infusing phenoxybenzamine and cocaine throughout the experiment. Using tritiated norepinephrine after preferential labeling of the heart by perfusion of the anterior descending coronary artery, a small release of neurotransmitter has been demonstrated in vivo with low-frequency stimulation (15) . Although this latter technique is sensitive, it has the disadvantage of measuring the release of exogenously administered amine which presumably could be derived on electrical nerve stimulation from different storage pools depending on the time between the administration of the labeled amine and the collection of the venous sample.
A selective release of endogenous norepinephrine from the dog heart in vivo on stimulation of cardioaccelerator nerves has been previously demonstrated (3) (4) (5) . Siegel et al. (3) have shown a frequency-dependent increase in the release of norepinephrine, suggesting a relationship between the amount of released amine and the intensity of physiological responses. In these experiments, however, each stimulation was given for periods of 5-10 minutes so that only crude relationships could be established between the release of norepinephrine and the corresponding cardiac responses.
Since it has been found that the liberation of cardiac norepinephrine and the physiological response are not constant throughout the whole period of stimulation (15) , the summation of the total amount of norepinephrine liberated during a long period of stimulation may not constitute an accurate estimation of the amount of norepinephrine liberated at the time of observation of the physiological response. It has been reported that very little overflow of norepinephrine occurs normally with stimulation frequencies on the order of 1-2 Hz (3). Most of the norepinephrine released under these conditions is thought to be inactivated by some local process (mainly by the neuronal reuptake mechanism) within the vicinity of the effector sites and thus prevented from overflowing into the venous effluent (6) . In the present experiments, however, a small change in the amount of endogenous catecholamine released from the heart could be detected at frequencies of 1-3 Hz under conditions in which active reuptake mechanisms were intact. This finding suggests that the venous content of catecholamines reflects more closely than previously thought the changes in catecholamine levels at the adrenergic nerve ending. It is likely that the release of catecholamine from the heart into coronary sinus blood in response to cardioaccelerator nerve stimulation is not a secondary effect due to changes in cardiovascular response, since it has also been observed under conditions in which heart rate and cardiac output are kept constant (3) .
Within the frequency range tested, plasma catecholamine levels increased linearly up to 10 Hz, but heart rate, left ventricular dP/dt, and mean left coronary blood flow responses followed a secondorder hyperbolic or exponential type of curve. Furthermore, slight increases in coronary sinus blood catecholamine levels at 1 and 3 Hz were associated with important cardiac responses. The small increases in coronary sinus blood catecholamine levels could be related to the observation that the local reuptake mechanism of adrenergic Circulation Research, Vol. 36, May 1975 fibers may be more efficient at low frequencies of stimulation (6, 14, 24) .
The liberation of catecholamine appeared to be reduced at a stimulation frequency of 30 Hz. The corresponding cardiac responses were also reduced at this stimulation frequency. The lower plasma catecholamine levels observed could be due to a diminished release possibly by exhaustion of readily available norepinephrine stores when a supraphysiological frequency of stimulation is employed (14, 16, 24) . Another explanation may be the occurrence of a local feedback inhibition by norepinephrine on alpha presynaptic receptors (20, 21, 25) . The frequency of stimulation that produced the maximum catecholamine level in coronary sinus blood and the maximum intensity of cardiac responses was 10 Hz, a finding which is in agreement with previous reports on the optimum frequency of sympathetic nerve stimulation (26) (27) (28) (29) .
In conclusion, using a sensitive micromethod for the measurement of plasma catecholamines, small changes in coronary sinus blood catecholamine levels could be detected on stimulation of the right cardioaccelerator nerves in anesthetized dogs at stimulation frequencies ranging from 1 to 30 Hz. The endogenous catecholamine levels in coronary sinus blood increased linearly up to a stimulation frequency of 10 Hz, but the cardiac responses increased exponentially. A significant degree of correlation existed between the amplitude of the response of the heart to sympathetic stimulation and the release of catecholamines into coronary sinus blood.
This approach may provide a means of relating the amount of sympathetic neurotransmitter released to the intensity of the cardiac responses to sympathetic nerve stimulation. The present preparation appears to be a promising tool for arriving at a better understanding of the role of the sympathetic nervous system in the control of cardiovascular function.
